Name
osaühing BioDesign
Registry code
10881645
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
23.08.2002 (22)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
86221 - Provision of specialised medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ivo Kolts 07.02.1957 (67) | 100% - 40 000.00 EEK | Board member | Direct ownership | Founder |
| 2019 25.11.2020 | 2020 08.06.2021 | 2021 21.07.2022 | 2022 13.09.2023 | |
|---|---|---|---|---|
| Total Revenue | 244 389 € | 218 431 € | 240 576 € | 199 163 € |
| Net profit (loss) for the period | -37 077 € | 9 736 € | 7 010 € | 24 458 € |
| Profit Margin | -15% | 4% | 3% | 12% |
| Current Assets | 182 801 € | 183 018 € | 195 375 € | 219 075 € |
| Fixed Assets | 721 595 € | 687 926 € | 942 701 € | 717 351 € |
| Total Assets | 904 396 € | 870 944 € | 1 138 076 € | 936 426 € |
| Current Liabilities | 69 361 € | 57 548 € | 238 411 € | 34 019 € |
| Non Current Liabilities | 154 488 € | 123 113 € | 202 372 € | 180 656 € |
| Total Liabilities | 223 849 € | 180 661 € | 440 783 € | 214 675 € |
| Share Capital | - | - | - | - |
| Equity | 680 547 € | 690 283 € | 697 293 € | 721 751 € |
| Employees | 7 | 7 | 6 | 6 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 8 638.97 € | 9 429.16 € | 5 |
| 2023 Q4 | - | 10 467.25 € | 11 327.77 € | 5 |
| 2023 Q3 | - | 12 262.74 € | 13 342.77 € | 5 |
| 2023 Q2 | - | 12 150.08 € | 13 134.57 € | 5 |
| 2023 Q1 | - | 11 685.78 € | 12 726.08 € | 5 |
| 2022 Q4 | - | 11 029.91 € | 11 903.12 € | 5 |
| 2022 Q3 | - | 8 826.91 € | 9 640.47 € | 7 |
| 2022 Q2 | - | 10 149.83 € | 11 079.8 € | 7 |
| 2022 Q1 | - | 8 805.13 € | 9 471.47 € | 8 |
| 2021 Q4 | - | 7 988.37 € | 8 705.87 € | 8 |
| 2021 Q3 | - | 12 285.09 € | 13 390.47 € | 7 |
| 2021 Q2 | - | 14 078.27 € | 15 354.03 € | 8 |
| 2021 Q1 | - | 10 923.05 € | 11 839.34 € | 8 |
| 2020 Q4 | - | 12 647.55 € | 13 817.65 € | 8 |
| 2020 Q3 | - | 8 348.46 € | 9 141.4 € | 8 |
| 2020 Q2 | - | 6 244.8 € | 6 826.63 € | 8 |
| 2020 Q1 | - | 12 304.61 € | 13 362.14 € | 8 |
